Bosset J F, Pelissier E P, Mantion G, Horiot J C, Pavy J J
Unité de Recherche Clinique en Cancérologie Digestive, Service de Radiothérapie-Oncologie, CHU Jean Minjoz, Besançon.
Ann Chir. 1996;50(4):302-10; discussion 311.
In December 1994, The French Consensus Conference on the Treatment of Rectal Cancer stated that: "Preoperative irradiation improves local control in T3 and T4 resectable rectal cancer patients and is recommended". Recent data indicate that this approach not only reduces local failure but also increases overall survival. The therapeutic ratio depends on the total dose delivered and technical parameters. Inadequate radiotherapy techniques leeds to increased toxicity and masks the potential benefits of the treatment. Combined preoperative chemo-radiotherapy, a promising issue in rectal cancer patients, is now under evaluation in a large European phase III trial (EORTC 22921).
1994年12月,法国直肠癌治疗共识会议指出:“术前放疗可改善T3和T4可切除直肠癌患者的局部控制,推荐使用”。近期数据表明,这种方法不仅能降低局部复发率,还能提高总生存率。治疗效果取决于总剂量和技术参数。放疗技术不当会导致毒性增加,并掩盖治疗的潜在益处。术前同步放化疗是直肠癌患者一个有前景的治疗方法,目前正在一项大型欧洲III期试验(EORTC 22921)中进行评估。